Patients living with sickle cell disease and thalassaemia will be eligible for the test
News
MIT researchers repurpose cancer compound to treat PKD
Autosomal dominant polycystic kidney disease affects more than 12 million people globally
Researchers advance blood tests’ ability to detect cancer earlier
The advancement could allow earlier detection of cancer in the blood and better treatment
NHS catch up campaign launched for missed MMR vaccines
Approximately one in five children will be hospitalised to treat measles
Virtual reality training to help NHS doctors spot signs of sepsis
Approximately 48,000 deaths in the UK occur from sepsis every year
Stroke experts to test emerging nerve stimulation treatment
New stroke therapy delivers electrical pulses to the brain
Serac to present data from DETECT study
Company will present vital findings at SRI annual meeting
UCB announces MHRA approval for UCB’s Zilbrysq
Green light concerns generalised myasthenia gravis therapy
Synendos receives EMA nod for brain therapy
Company is focused on endocannabinoid system treatments
StemSight and ERS Genomics focus on collaboration
License agreement concerns development of cell therapies for corneal blindness
Poolbeg’s cytokine release syndrome drug shows potential
Data supports Poolbeg’s strategic expansion of POLB 001
Disco tunes into new cancer drug targets
EUR 20m to identify new targets and develop first in class drugs
Aston University receives £10m for membrane institute
Aston University to create the Aston Institute for Membrane Excellence
CellVoyant secures £7.6 million AI stem cell boost
CellVoyant’s platform combines AI with live cell imaging
Kanabo and City Dock Pharmacy team up
Companies collaborate to launch walk-in pain clinic
